Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Jan. 31, 2026 |
Jan. 31, 2025 |
Jan. 31, 2026 |
Jan. 31, 2025 |
|
| Expenses: | ||||
| Consulting | $ 75,250 | $ 93,200 | $ 255,250 | $ 429,992 |
| General and administrative | 68,503 | 223,603 | 217,914 | 421,758 |
| Total expenses | 143,753 | 316,803 | 473,164 | 851,750 |
| Loss from operations | (143,753) | (316,803) | (473,164) | (851,750) |
| Other income (expense): | ||||
| Gain (loss) on debt settlement | 0 | 50,166 | (1,500) | 773,231 |
| Interest and other income (expense) | (28,740) | (6,408) | (42,058) | (30,562) |
| Gain (loss) on accounts payable | 0 | 0 | 0 | (250,000) |
| Loss on Origination fee | (1,000) | (43,529) | 0 | |
| Debt discount | (3,000) | 0 | (3,000) | 0 |
| Gain (loss) on derivative liability | (15,312) | 5,633 | (36,779) | 13,090 |
| Total other income (expense) | (48,052) | 49,391 | (126,866) | 505,759 |
| Income (loss) before income taxes | (191,805) | (267,412) | (600,030) | (345,991) |
| Provision for income taxes | 0 | 0 | 0 | 0 |
| Net income (loss) before non-controlling interest | (191,805) | (267,412) | (600,030) | (345,991) |
| Non- controlling interest in net income (loss) of the consolidated subsidiary | 9,440 | 5,366 | 35,559 | 15,867 |
| Net income (loss) attributed to the Company | $ (182,365) | $ (262,046) | $ (564,471) | $ (330,124) |
| Net income (loss) per common share: Basic and diluted | $ (0.00) | $ (0.01) | $ (0.00) | $ (0.01) |
| Weighted average common shares outstanding: | ||||
| Basic and diluted | 37,531,757 | 32,207,256 | 35,481,003 | 27,175,776 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Represents the charge against earnings during the period for commitment fees and debt issuance expenses. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross amount of debt extinguished. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale of accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|